{"id":5589,"date":"2023-03-14T10:59:12","date_gmt":"2023-03-14T09:59:12","guid":{"rendered":"https:\/\/ww2.omceoge.it\/?page_id=5589"},"modified":"2023-03-16T10:49:23","modified_gmt":"2023-03-16T09:49:23","slug":"5589-alisa-prot-n-5397-del-13-03-2023-sospensione-di-utilizzo-del-medicinale-molnupiravir-lagevrio","status":"publish","type":"post","link":"https:\/\/www.omceoge.it\/home9\/item\/5589-alisa-prot-n-5397-del-13-03-2023-sospensione-di-utilizzo-del-medicinale-molnupiravir-lagevrio\/","title":{"rendered":"<img src=\"https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png\" class=\"custom-title-icon\" style=\" vertical-align:middle; display:inline-block;\">ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)"},"content":{"rendered":"<p>Pubblichiamo la comunicazione di Alisa prot. 5397 e la comunicazione n. 34 della FNOMCeO relativa alla Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)<\/p>\n<hr class=\"readMore\">\n<div class=\"allegati_pdf\">\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/alisa.REGISTRO_UFFICIALE.2023.0005397.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Alisa prot. 5397<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/allegato_1_2.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Allegato 1<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/allegato_2_2.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Allegato 2<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/Copia_DocPrincipale_COM_N_34.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">FNOMCeO COMUNICAZIONE N. 34<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/all1_19.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 5397 &#8211; FNOMCeO- COMUNICAZIONE N. 34 &#8211;  Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Allegato <\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pubblichiamo la comunicazione di Alisa prot. 5397 e la comunicazione n. 34 della FNOMCeO relativa alla Sospensione di utilizzo del medicinale Molnupiravir (Lagevrio)<\/p>\n","protected":false},"author":563,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,144],"tags":[],"class_list":["post-5589","post","type-post","status-publish","format-standard","hentry","category-news-dell-ordine","category-news1"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/5589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/users\/563"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/comments?post=5589"}],"version-history":[{"count":0,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/5589\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/media?parent=5589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/categories?post=5589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/tags?post=5589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}